Impoyz Cream contains Clobetasol 0.025% w/w, a potent topical corticosteroid indicated for the treatment of various inflammatory and pruritic dermatoses responsive to corticosteroid therapy. Clobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by inhibiting multiple inflammatory cytokines and mediators, thereby reducing erythema, swelling, and itching. Impoyz Cream is commonly prescribed for conditions such as psoriasis, eczema, dermatitis, and lichen planus. It is intended for external use only and should be applied sparingly to the affected area, typically once or twice daily, as directed by a healthcare professional. Prolonged or excessive use may lead to local adverse effects including skin atrophy, telangiectasia, and secondary infections. Systemic absorption, although minimal when used appropriately, can occur and may result in hypothalamic-pituitary-adrenal (HPA) axis suppression, particularly when applied over large surface areas or under occlusion. Therefore, treatment duration should be limited, and patients should be monitored for potential side effects. Impoyz Cream is contraindicated in viral, bacterial, or fungal skin infections and hypersensitivity to Clobetasol or any cream excipients. Pregnant or lactating women should use this medication only if clearly needed and under medical supervision.